Amedeo Smart

Free Medical Literature Service

 

Amedeo

Liver Transplantation
  Free Subscription

Articles published in
PLoS One
    January 2026
  1. MILISAVLJEVIC J, Stosic M, Jovanovic N, Adzic Vukicevic T, et al
    Latent TB infection in solid organ transplant recipients in Serbia: A single center experience from a low TB burden country.
    PLoS One. 2026;21:e0339925.
    >> Share

  2. WAKIYA T, Sanada Y, Okada N, Hirata Y, et al
    Data-driven predictive modeling for massive intraoperative blood loss during living donor liver transplantation: Integrating machine learning techniques.
    PLoS One. 2026;21:e0326000.
    >> Share

  3. WANG G, Liu L, Zhang H, Mao P, et al
    Effects of tacrolimus treatment on the gut microbiota and metabolites in liver transplant recipients.
    PLoS One. 2026;21:e0343817.
    >> Share

  4. TRAN Z, Raykateeraroj N, Suh J, Ismail J, et al
    Effects of massive transfusion (10-20 litres) versus ultramassive transfusion (>/=20 litres) on mortality in adult liver transplant recipients: A propensity-score matched study.
    PLoS One. 2026;21:e0349795.
    >> Share

  5. SAKKA R, Abroug H, Youssef SB, Mekki M, et al
    Types of genotypes in progressive familial intrahepatic cholestasis and liver transplantation: A meta-analysis of observational studies.
    PLoS One. 2026;21:e0350508.
    >> Share

  6. IMAMURA H, Ito R, Ichida H, Yoshioka R, et al
    Age-range-matched external validation of standard liver volume equations: Methodological re-evaluation of 13 regression models.
    PLoS One. 2026;21:e0351983.
    >> Share

  7. ALDILA D, Rahman NS, Majere A, Fatmawati, et al
    Mathematical modeling of HBV-HDV transmission with superinfection: The role of vaccination and liver transplantation in disease dynamics.
    PLoS One. 2026;21:e0356725.
    >> Share

  8. BORAKATI A, Agilinko J, Wu J, Hunter S, et al
    The applications of artificial intelligence in liver transplantation: A comprehensive scoping review.
    PLoS One. 2026;21:e0361120.
    >> Share

  9. ULUK D, Liu W, Jiang D, Stoppe C, et al
    MIF inhibitor ISO-1 attenuates ischemia-reperfusion injury in a rat model of donation after circulatory death liver transplantation.
    PLoS One. 2026;21:e0361214.
    >> Share

    January 2025
  10. SHOURABIZADEH H, Aleman DM, Rousseau LM, Zheng K, et al
    Classification-augmented survival estimation (CASE): A novel method for individualized long-term survival prediction with application to liver transplantation.
    PLoS One. 2025;20:e0315928.
    >> Share

  11. OHIRA M, Imaoka Y, Sato K, Imaoka K, et al
    A phase I/II study of adoptive immunotherapy using donor liver graft-derived NK cell-enriched immune cells to prevent severe infection after liver transplantation.
    PLoS One. 2025;20:e0313102.
    >> Share

  12. MIYAGAWA-HAYASHINO A, Imura T, Takezawa T, Hirai M, et al
    Activation of S1PR2 on macrophages and the hepatocyte S1PR2/RhoA/ROCK1/MLC2 pathway in vanishing bile duct syndrome.
    PLoS One. 2025;20:e0317568.
    >> Share

  13. CHEN K, Yang M, Li G, Wang W, et al
    Liver transplantation for NASH-related hepatocellular carcinoma versus non-NASH etiologies of hepatocellular carcinoma: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0317730.
    >> Share

  14. DALMAU M, Charco R, Bilbao I, Dopazo C, et al
    Heparinase I treatment to overcome RNA quantification interference in heparinized liver donor samples: One size fits all?
    PLoS One. 2025;20:e0322899.
    >> Share

  15. SLIFIRSKI H, Raykateeraroj N, Armellini A, Hazard R, et al
    Ultra-massive fluid transfusion in adult liver transplant recipients: A single center observational study.
    PLoS One. 2025;20:e0325829.
    >> Share

  16. LIU L, Wang Q, Qin S, Su C, et al
    Comprehensive characterization of the competitive endogenous RNA network revealing its immune-related functions in hepatic ischemia-reperfusion injury.
    PLoS One. 2025;20:e0327101.
    >> Share

  17. AL-HUSSAINI A, AlMannai M, Alruwaithi M, Faqeih E, et al
    Clinical and molecular characterization of hepatic glycogen storage disease in Saudi Arabia.
    PLoS One. 2025;20:e0329008.
    >> Share

  18. SCHREINER AD, Zhang J, Gebregziabher M, Marsden J, et al
    The association of race with time to severe liver disease diagnoses.
    PLoS One. 2025;20:e0334016.
    >> Share

  19. ALQAHTANI SA, AlMuhaidib S, Raptis DA, Al-Hamoudi WK, et al
    Metabolic dysfunction-associated steatohepatitis is the leading indication for adult liver transplantation in Saudi Arabia.
    PLoS One. 2025;20:e0338438.
    >> Share

  20. LOPEZ-DIAZ G, Sanchez-Lorencio MI, Inarrairaegui M, Gonzalez-Dieguez ML, et al
    Longitudinal biomarker progression and validation for predicting operational tolerance in a prospective multicenter liver transplantation immunosuppression withdrawal trial.
    PLoS One. 2025;20:e0326442.
    >> Share

    January 2024
  21. GITTUS M, Moore J, Ong ACM
    Liver transplant recipients with polycystic liver disease have longer waiting times but better long-term clinical outcomes than those with liver disease due to other causes: A retrospective cross-sectional study.
    PLoS One. 2024;19:e0294717.
    >> Share

  22. LAUE T, Junge N, Leiskau C, Mutschler F, et al
    Diminished measles immunity after paediatric liver transplantation-A retrospective, single-centre, cross-sectional analysis.
    PLoS One. 2024;19:e0296653.
    >> Share

  23. LIU W, Jiang D, Schulz M, Figueiredo C, et al
    Machine perfusion of the liver and in vivo animal models: A systematic review of the preclinical research landscape.
    PLoS One. 2024;19:e0297942.
    >> Share

  24. AZAMAR-LLAMAS D, Arenas-Martinez JS, Olivas-Martinez A, Jimenez JV, et al
    Impact of COVID-19 vaccination on liver transplant recipients. Experience in a reference center in Mexico.
    PLoS One. 2024;19:e0301198.
    >> Share

  25. WILSON EA, Woodbury A, Williams KM, Coopersmith CM, et al
    OXIDATIVE study: A pilot prospective observational cohort study protocol examining the influence of peri-reperfusion hyperoxemia and immune dysregulation on early allograft dysfunction after orthotopic liver transplantation.
    PLoS One. 2024;19:e0301281.
    >> Share

  26. YUAN C, Li W, Liu J, Li J, et al
    Frailty and transplant-free survival of patients with liver cirrhosis: A meta-analysis.
    PLoS One. 2024;19:e0302836.
    >> Share

  27. WEINBERG L, Caragata R, Hazard R, Ludski J, et al
    Venovenous bypass in adult liver transplant recipients: A single-center observational case series.
    PLoS One. 2024;19:e0303631.
    >> Share

  28. WOLPERT BM, Rothgerber DJ, Rosner AK, Brunier M, et al
    Evaluation of dynamic cerebrovascular autoregulation during liver transplantation.
    PLoS One. 2024;19:e0305658.
    >> Share

    January 2023
  29. LE FLOC'H B, Costet N, Vu N, Bernabeu-Gentey P, et al
    Involvement of circulating soluble HLA-G after liver transplantation in the low immunogenicity of hepatic allograft.
    PLoS One. 2023;18:e0282736.
    >> Share

  30. CHO Y, Lee JE, Jeong H, Kwon JH, et al
    Cumulative postoperative change in serum albumin levels and organ failure after living-donor liver transplantation: A retrospective cohort analysis.
    PLoS One. 2023;18:e0285734.
    >> Share

  31. FITZPATRICK E, Filippi C, Jagadisan B, Shivapatham D, et al
    Intraperitoneal transplant of Hepatocytes co-Encapsulated with mesenchymal stromal cells in modified alginate microbeads for the treatment of acute Liver failure in Pediatric patients (HELP)-An open-label, single-arm Simon's two stage phase 1 study pr
    PLoS One. 2023;18:e0288185.
    >> Share

  32. KITAHARA J, Yoshinaga T, Kakihara S, Hirano T, et al
    Ocular findings in patients with acquired ATTRv amyloidosis following domino liver transplantation.
    PLoS One. 2023;18:e0291716.
    >> Share

  33. MOON JJ, Hong SK, Kim YC, Hong SY, et al
    Soluble suppression of tumorigenicity 2 is a potential predictor of post-liver transplant renal outcomes.
    PLoS One. 2023;18:e0293844.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016